Kurt R. Weiss, MD
Department of Orthopaedic Surgery, Division of Musculoskeletal Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Dr. Kurt R. Weiss is a native Pittsburgher who has been involved with orthopaedic research since 1994 when he performed orthopaedic basic science research as an undergraduate student. Today, he is an Associate Professor of Orthopaedic Surgery in the University of Pittsburgh School of Medicine Department of Orthopaedic Surgery, Division of Musculoskeletal Oncology. He also directs the Department’s Musculoskeletal Oncology Laboratory. Dr. Weiss attended Jefferson Medical College in Philadelphia, during which he participated in a 1-year research fellowship at the National Institutes of Health where he studied the biology of pediatric bone cancers. Dr. Weiss returned to Pittsburgh for his residency in orthopaedic surgery, which included another dedicated research year. He completed a fellowship in musculoskeletal oncology at the University of Toronto. In addition to his clinical practice in pediatric and adult musculoskeletal oncology, Dr. Weiss directs the Musculoskeletal Oncology Laboratory, a basic science lab dedicated to the study of sarcomas--cancerous tumors that arise in the musculoskeletal tissues-and metastatic bone disease. He holds a K08 Career Development Award from the National Cancer Institute to develop a translational sarcoma research program at the University of Pittsburgh. As a bone cancer survivor himself, Dr. Weiss brings passion and enthusiasm to the laboratory, clinic, and operating room. He also has an R21 grant from the NCI to study the poorly understood phenomenon of Sarcoma-Associated Cachexia. Through the UPMC Hillman Cancer Center, he is also a proud collaborator with several scientists who are trying to understand how other forms of cancer, particularly breast cancer, spread to and destroy the bone. He has served on the NCI Molecular Oncology Study Section.
Dr. Weiss has received many accolades which include: 1). 2016-17 American Academy of Orthopaedic Surgeons Leadership Fellows Program; 2). 2015 Pittsburgh Business Time Health Care Heroes Award Winner; 3). 2013 University of Pittsburgh Cancer Institute Junior Scholar Award; 4). Named one of Pittsburgh’s “40 Under 40” by Pittsburgh Magazine in 2013; 5). 2012 Courage Award from the Sarcoma Foundation of America.
He is a Founding Member of the Pittsburgh Sarcoma Research Collaborative, the Musculoskeletal Oncology Research Initiative, Pittsburgh Cure Sarcoma, and the Pittsburgh Center for Bone and Mineral Research. He is on the editorial staffs of the Journal of the American Academy of Orthopaedic Surgeons, BioMed Central Cancer, and Frontiers In Surgery. He reviews for Sarcoma, Cancer Research, International Journal of Cancer, and other journals. He has been accepted to the NIH’s Center for Scientific Review Early Career Reviewer program. He is a member of the Musculoskeletal Tumor Society (MSTS) the Connective Tissue Oncology Society (CTOS), for which he serves on the Board of Directors.
Terms of Appointment: March 2018 - February 2020